Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and ZD1839 in Nasopharyngeal Carcinoma
NCT00212108Phase 2Completed
- Sponsor
- National University Hospital
- Start
- Nov 2003
- Primary completion
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib, gefitinib in nasopharyngeal carcinoma (NPC), sponsored by National University Hospital. Started Nov 2003; status: completed.
02
Drugs
celecoxibgefitinib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00212108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212108.